I also think there are opportunities in Canada, even though the industrial sector is not developed as well. You probably know that the pharmaceutical sector and biopharmaceutical sector is completely changing in Canada, with all these big pharmas moving out of fundamental research. There's a task force of amazing scientists who can contribute and be a part, and startup companies we should subsidize differently, as well. There's a new model that needs to operate with this high-risk research that can lead to potentially great discoveries and new technologies for treating cancers, and resistant bacteria, and so on.
Diagnostics is one of the areas coming very quickly in the nanotechnology agenda. It's already there.